Anthropic Inc. completes its IPO on the Nasdaq by November 30, 2026 (confirmed by Anthropic press release or Bloomberg by December 1, 2026)
Pending
✦ AI-generated prediction
Published on 29. September 2026
·
Predicted for 30. November 2026
·
Based on: Speculative
Anthropic has already postponed its originally targeted October 2026 Nasdaq IPO twice (most recently per TechCrunch on September 13, 2026). Prediction markets currently show 58.5% probability for completion by November 30, 2026 and 75.5% by December 31, 2026 (Polymarket, as of September 29, 2026). The company is officially IPO-ready and considered one of the year's most anticipated tech listings; Nscale also targets October 2026 and SpaceX/OpenAI eye H2 2026. Counterargument: multiple postponements and AI-regulatory complexity could push the timeline back again. Calibrated to Polymarket market quote of 58.5%.
Data basis for this prediction
- Polymarket: Anthropic IPO bis 30.11.2026 = 58,5 % (Stand 29.09.2026)
- Polymarket: Anthropic IPO bis 31.12.2026 = 75,5 % (Stand 29.09.2026)
- TechCrunch: Anthropic IPO zweimal von Oktober-Ziel verschoben (13.09.2026)
- CryptoBriefing / EquityZen 2026 IPO Outlook: Anthropic November-Fenster als wahrscheinlichstes Timing (Sept 2026)
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
💻 Technology
✦ AI
Chemistry World and Clarivate identify David R. Liu (Harvard University / Broad Institute) as the leading candidate for the 2026 Nobel Prize in Chemistry (announced October 8, 2026). Liu developed base editing in 2016 and prime editing in 2019 — precise genome editing methods without DNA double-strand breaks, safer and more efficient than CRISPR-Cas9. No liquid prediction market available. The 18% probability reflects the inherent unpredictability of the Nobel Committee. Alternative candidates: Shankar Balasubramanian & David Klenerman (DNA sequencing, 2026 Princess of Asturias Prize winners — historically a strong Nobel signal).
💻 Technology
✦ AI
All three were jointly named 2026 Clarivate Citation Laureates for GLP-1 discovery — a predictor with strong historical Nobel correlation. Holst and Drucker also received the 2026 Breakthrough Prize in Life Sciences. Joel Habener's death (2025/26) reduces the viable laureate group to three, simplifying the award. A GLP-1 Nobel is considered medically 'overdue' (Ozempic revolution). No liquid prediction market found for Nobel Medicine 2026 (no Polymarket or Kalshi contract active as of Sept 28, 2026). Probability honestly calibrated at 38%, as the Medicine Nobel regularly surprises.
💻 Technology
✦ AI
The Kalshi market for Nobel Physics 2026 (~$8K volume, very thin) lists Kane, Kitaev, and Preskill as top candidates at ~24–30¢ each. A Physics Forums community market briefly priced E. Mele at 97% — either an insider signal or manipulation, but it illuminates sentiment. Kane & Mele described the quantum spin Hall effect in 2005, the theoretical seed of all topological quantum states; Kane received the 2023 Lorentz Medal. Serious alternative candidates: Alexei Kitaev (topological quantum computing), Qikun Xue (experimental confirmation), Aharonov/Berry (geometric phases). Honestly calibrated at 26% — the Physics prize remains structurally unpredictable.